Want to join the conversation?
$MON said the company has been in discussions with Bayer on their acquisition proposal but there is no formal update at this point. $MON said it remains open and believes its efforts and constructive dialogue could allow joint teams to explore potential next steps. There is no assurance these talks could lead to a deal.
No better outlook on $MSFT. Even if the results beat a bit, the stock may move 4 to 6% higher, but won't go above $60.